4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid has been researched along with Thrombopenia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bagshawe, KD; Begent, RH; Cushen, N; Green, AJ; Martin, J; Napier, MP; O'Malley, D; Sharma, SK; Springer, CJ; Stribbling, SM | 1 |
1 trial(s) available for 4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid and Thrombopenia
Article | Year |
---|---|
Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; gamma-Glutamyl Hydrolase; Glutamates; Humans; Male; Middle Aged; Neutropenia; Nitrogen Mustard Compounds; Prodrugs; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2000 |